TickerFacts.

Regeneron Pharmaceuticals, Inc. (REGN): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$402.80M
Year ended 2019-12-31
2018-12-31: $237.50M2019-12-31: $402.80M$402.80M
2018-12-31 Cost of Revenue (USD) 2019-12-31
Period endedCost of RevenueChange YoYSource filing
2019-12-31$402.80M+69.6%2021-02-08, From 2019-01-01
2018-12-31$237.50Mn/a2021-02-08, From 2018-01-01